Constance Therapeutics has been awarded its third patent by U.S. Patent and Trademark Office
We are pleased to announce that our group company Constance Therapeutics (CT) has been awarded its third patent by U.S. Patent and Trademark Office. The patent has been issued as U.S. Pat. No. 10,806,707, titled “Cannabis Oil Compositions and Methods for Preparations...
Constance LifeSciences Corp. / Constance Pure Botanical Extracts is a Section 215 Compliant collective located in the San Francisco Bay Area, California. Copyright © 2021
DISCLAIMER: These statements have not been evaluated by the United States Food and Drug Administration. The U.S. federal government (including the FDA) maintains that cannabis is a Schedule 1 drug under the federal Controlled Substances Act, with no accepted medical use, despite the mounting evidence from the international medical community. As a result, our products cannot go through FDA testing that would enable us to make health claims, and we are required to state that Constance LifeSciences Corp. & Constance Pure Botanical Extracts products are not intended to diagnose, treat, cure, or prevent any disease, illness or medical condition. Constance LifeSciences Corp. & Constance Pure Botanical Extracts makes no healing, curative or medical claims or warranties regarding its products. If you have a medical condition or illness, please consult your physician.